Published in Arch Dermatol on March 01, 2001
Icodextrin-associated hepatotoxicity. NDT Plus (2011) 0.75
A case report on allergic rash caused by icodextrin. Case Rep Nephrol Dial (2014) 0.75
Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol (2001) 4.34
Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br J Dermatol (2013) 2.38
Skin pigmentary anomalies and mosaicism for an acentric marker chromosome originating from 3q. J Med Genet (1999) 2.00
A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol (2003) 1.73
The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant (1999) 1.72
Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid? Eur J Dermatol (2001) 1.64
Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology (1993) 1.64
Hippocrates on necrotising fasciitis. Lancet (1994) 1.43
Hypochromic vitiligo: delineation of a new entity. Br J Dermatol (2014) 1.42
[Reasonable hospital use of mupirocin]. Ann Dermatol Venereol (2000) 1.40
Cloxacillin versus pristinamycin for superficial pyodermas: a randomized, open-label, non-inferiority study. Dermatology (2005) 1.38
Anti-TNF-alpha-induced systemic lupus syndrome. Clin Rheumatol (2003) 1.32
Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol (2003) 1.20
[Management of drug reaction with eosinophilia and systemic symptoms (DRESS)]. Ann Dermatol Venereol (2010) 1.16
Association study of the g.8818A>G polymorphism of the human agouti gene with melanoma risk and pigmentary characteristics in a French population. J Dermatol Sci (2005) 1.11
Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet (2004) 1.10
A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol (2004) 0.99
Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol (1997) 0.98
PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study. Br J Cancer (2006) 0.97
Recurrent erysipelas: 47 cases. Dermatology (2007) 0.96
[Prognostic factors and predictive signs of malignancy in adult dermatomyositis]. Ann Dermatol Venereol (1996) 0.93
LacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors. Gene Ther (1996) 0.93
[Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies]. Ann Med Interne (Paris) (2000) 0.93
[Pyoderma gangrenosum with aseptic spleen abscess]. Ann Dermatol Venereol (2008) 0.91
Simultaneous IgA nephropathy and Wegener's granulomatosis--overlap or coincidence (the role of renal biopsy). Nephrol Dial Transplant (1999) 0.91
CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab. Br J Dermatol (2003) 0.90
[Cutaneous revelation of Rosai-Dorfman disease: 7 cases]. Ann Dermatol Venereol (2012) 0.89
Intravenous immunoglobulins-induced eczematous eruption: a long-term follow-up study. Eur J Intern Med (2008) 0.88
Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients. Arch Dermatol (1994) 0.88
[A case of malignant melanoma expressing epithelial cell markers in immunohistochemistry using paraffin sections]. Ann Pathol (1990) 0.86
Dramatic improvement of atopic keratoconjunctivitis after topical treatment with tacrolimus ointment restricted to the eyelids. J Eur Acad Dermatol Venereol (2009) 0.85
Plasma exchange in bullous pemphigoid. Lancet (1984) 0.85
[Videomicroscopy in alopecia areata]. Ann Dermatol Venereol (2007) 0.85
[Undergraduate medical education. Students' perspective and medical school policy]. Presse Med (2000) 0.85
Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study. Br J Dermatol (2012) 0.85
Acute renal and hepatic failure: do not miss pericardial tamponade! Nephrol Dial Transplant (1999) 0.85
[Scleroderma and environment. I. Scleroderma and sclerodermiform states induced by silica and chemical agents or drugs]. Ann Dermatol Venereol (1991) 0.83
[Dermatomyositis in childhood with recurrence in adulthood: 2 cases]. Ann Dermatol Venereol (1993) 0.82
[Correlation between the presence of type-2 anti-pemphigoid antibodies and dementia in elderly subjects with no clinical signs of pemphigoid]. Ann Dermatol Venereol (2006) 0.82
Hepatitis C virus infection in cutaneous polyarteritis nodosa: a retrospective study of 16 cases. Arch Dermatol (1999) 0.82
Merkel cell carcinoma in a black human immunodeficiency virus-infected patient. Br J Dermatol (2002) 0.82
[MALT (Mucosal Associated Lymphoid Tissue) lymphoma of the palpebral conjunctiva]. Ann Dermatol Venereol (2006) 0.82
Strontium ranelate-induced DRESS syndrome: first two case reports. Allergy (2009) 0.82
Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma. Br J Cancer (2004) 0.81
Results of a comprehensive hospital-based wound survey. J Wound Care (2006) 0.81
High frequency of detection of human papillomaviruses associated with epidermodysplasia verruciformis in children with psoriasis. Br J Dermatol (2003) 0.81
Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol (2004) 0.81
Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate. Osteoporos Int (2013) 0.81
Bullous pemphigoid induced by vaccination. Br J Dermatol (1996) 0.80
[Cutaneo-mucous leishmaniasis in HIV infection]. Ann Dermatol Venereol (1991) 0.80
Sclerodermiform aspect of arm lymphoedema after treatment with docetaxel for breast cancer. J Eur Acad Dermatol Venereol (2007) 0.80
Global improvement of systemic scleroderma under long-term administration of octreotide. Eur J Dermatol (1999) 0.80
Prednisone is more effective than prednisolone metasulfobenzoate in the treatment of bullous pemphigoid. Arch Dermatol (1999) 0.80
Effects of atorvastatin on dyslipidaemia in uraemic patients on peritoneal dialysis. Nephrol Dial Transplant (2000) 0.80
[Local corticosteroid therapy in dermatology]. Presse Med (1999) 0.79
[Spondylodiscitis revealing bacterial endocarditis]. Ann Med Interne (Paris) (1976) 0.79
[Cutaneous necrosis is predictive of cancer in adult dermatomyositis]. Ann Dermatol Venereol (2003) 0.79
[Sclerodermal cardiopathy. Apropos of 155 cases of generalised scleroderma]. Arch Mal Coeur Vaiss (1980) 0.79
[External anogenital condylomas]. Ann Dermatol Venereol (2002) 0.79
[Therapy of chronic non infectious uveitis]. Rev Med Interne (2006) 0.79
[Post-varicella anetoderma. 3 cases]. Ann Dermatol Venereol (1990) 0.78
[Filiform palmar hyperkeratosis and rectosigmoid cancer]. Ann Dermatol Venereol (1988) 0.78
[Cutaneous manifestations during disseminated trichosporonosis in an AIDS patient]. Ann Dermatol Venereol (1998) 0.78
Mid dermal elastolysis. Report of a case with a predominant perifollicular pattern. J Am Acad Dermatol (1992) 0.78
Childhood-onset psoriasis: association with future cardiovascular and metabolic comorbidities. Br J Dermatol (2013) 0.78
[Alpha interferon-induced eczema in atopic patients infected by hepatitis C virus: 4 case reports]. Ann Dermatol Venereol (2000) 0.78
Immune recovery inflammatory folliculitis. AIDS (2000) 0.77
[Parvovirus B19 infection mimicking drug-induced hypersensitivity syndrome]. Ann Dermatol Venereol (2000) 0.77
[Bullous pemphigoid and acquired hemophilia]. Ann Dermatol Venereol (2007) 0.77
Intravenous immunoglobulins as a treatment of interstitial granulomatous dermatitis with arthritis. Br J Dermatol (2012) 0.77
Granulomatous foreign-body reaction with facial dermal fillers after omalizumab treatment for severe persistent allergic asthma: a case report. Br J Dermatol (2012) 0.77
[Anti-beta 2 glycoprotein 1 antibodies in idiopathic livedo reticularis]. Ann Dermatol Venereol (1995) 0.77